Osivax

Quick facts

Phase 2 pipeline

• Afluria Quad · Immunology / Infectious Disease
  Afluria Quad is a quadrivalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus.
• OVX836
• OVX836-003
• OVX836 480µg
• OVX836 shot

Phase 1 pipeline

• OVX033

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Osivax portfolio CI brief
• Osivax pipeline updates RSS